10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2024
3:54 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:07 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:44 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/08/2024
3:44 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:56 PM | X4 Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/11/2024
3:01 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:28 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:40 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:17 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
7:01 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
7:09 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:58 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
5:28 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
7:30 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
5:30 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:30 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:20 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:08 PM | X4 Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
6:43 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:19 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:19 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:16 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:52 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4/A | |
02/14/2024
6:36 PM | ORBIMED ADVISORS LLC (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
3:44 PM | ACORN BIOVENTURES, L.P. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
02/13/2024
5:55 PM | Bain Capital Life Sciences Fund, L.P. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:23 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:23 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
3:27 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
3:28 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:09 PM | BlackRock Inc. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
9:26 AM | Empery Asset Management, LP (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/27/2023
4:20 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
11/14/2023
3:10 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:11 PM | X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
7:07 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:26 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:39 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:39 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:40 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:42 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
